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Acute conjunctivitis can be caused by viruses
including enterovirus 70 (EV-70), coxsackievirus
A24, and epidemic adenoviruses. These viruses
may also lead to acute hemorrhagic conjunctivi-
tis (AHC), characterized by photophobia,
watering, and foreign body sensation, eyelid
edema, conjunctival hemorrhages, and superfi-
cial punctate keratitis. The disease is self-
limiting.
In 1996, an outbreak of AHC occurred in
Delhi, north India, during the rainy season
(August and September). We conducted a study
to identify the etiologic agent by viral culture,
immunofluorescence and neutralization tests,
and polymerase chain reaction (PCR).
The Study
We enrolled 13 patients with clinically
diagnosed bilateral AHC who attended the
outpatient clinic of Rajendra Prasad Centre for
Ophthalmic Sciences during the outbreak. At the
initial visit, all patients had a complete
ophthalmic examination, including slit-lamp
biomicroscopy. Conjunctival swabs were taken
from the right eye of each patient. These swabs
were collected in 2 ml of Hanks balanced salt
solution with antibiotics and were transported
on wet ice to the virology laboratory for
processing.
All samples were vortexed thoroughly and
treated with antibiotics (1,000 IU/ml penicillin
and 1,000 µg/ml streptomycin). Specimens were
clarified by centrifugation at 700 x g for 10
minutes at 4°C. Supernatant fluid was separated
and used for inoculation in cell culture. The
samples were stored at -70°C until they were
processed.
For virus culture, Hep-2cell monolayers
were grown in 24-well plates, containing 12-mm
cover slips (Bellco Glass Inc., New Jersey, USA).
Each plate was seeded with 1 ml of Hep-2cell
suspension, incubated at 37°C in a 5% CO2
atmosphere, and used for a modification of the
centrifugation-enhanced viral culture technique
(1).
Cover-slip monolayers were washed twice
with phosphate-buffered saline (PBS) before
specimen inoculation. Two hundred microliters
of each specimen was inoculated in parallel in
two 24-well plates containing Hep-2cell
monolayers grown onto 12-mm cover slips.
Plates were centrifuged at 700 x g for 60 minutes
at room temperature. Inoculum was discarded
and washed once with PBS; infected cells were
re-fed with 1.0 ml of Eagles minimum essential
medium containing 2% fetal calf serum. The
plates were reincubated at 37°C in a 5% CO2
atmosphere. Cover slips from one plate were
removed, washed twice with PBS, and fixed with
chilled acetone at 48 hours postinoculation for
immunofluorescence. The parallel 24-well plate
cultures were observed for viral cytopathic
effect, which included rounding and refractility
of cells and destruction of the monolayer at 2 to 4
days; the resulting effect suggested enteroviral
infection. Because a standardized reverse
transcriptase-PCR test for enteroviral RNA was
available at the All India Institute of Medical
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Sciences, New Delhi, India, we screened the
samples with this test.
Ten of the 13 clinical samples and the
positive control showed the amplicon band, while
the negative control did not (Figure). The PCR
results suggested enteroviral infection,  helped
narrow the search for the etiologic agent, and
provided a rapid preliminary diagnosis.
Viral antigen was detected by indirect
immunofluorescence staining (on the fixed cover
slips stored earlier) using specific antibodies to
EV70, coxsackievirus A24, and adenoviruses
(Chemicon International Inc., CA, USA).
Infected cover-slip monolayers were stained with
25 µl of monoclonal antibodies, incubated in a
moist chamber at 37°C for 45 minutes, and
washed twice with PBS for 10 minutes each.
Fluorescein-labeled anti-mouse conjugate was
added, and the cover slips were reincubated at
37°C for 45 minutes, followed by a PBS washing
step, as described above. The cover slips were air-
dried, mounted with glycerol buffer, and
examined under fluorescence microscopy.
The samples showing a viral cytopathic
effect were given a second passage, and if the
effect was seen again, the 50% tissue infective
dose of the virus isolate was calculated. A virus
neutralization test was performed using 100 50%
tissue infective doses of the isolate and virus-
specific antiserum.
Findings
All 13 patients enrolled in the study (9 male
and 4 female, ages 14 to 37 years) had bilateral
ocular involvement and described redness and
watering of the eyes, mild photophobia, and
severe foreign body sensation. Ocular examina-
tion showed severe conjunctival congestion,
interspersed subconjunctival hemorrhages, and
superficial punctate epithelial keratitis. No
neurologic manifestations (as reported in an
earlier epidemic) were observed (4).
Cover-slip monolayers infected with a known
EV-70 prototype (Kono)like strain from a
previous outbreak (5) and 10 of the 13 clinical
specimens showed specific cytoplasmic fluores-
cence with monoclonal antibodies to EV-70.
Infected monolayers tested with monoclonal
antibodies to adenovirus and coxsackievirus A24
yielded negative results. Neutralization test
results confirmed the identification, as all 10
clinical isolates were neutralized by EV-70
specific antisera. Also, the known EV-70
prototype (Kono)like strain was neutralized by
pooled convalescent-phase sera from the pa-
tients in this outbreak. PCR was positive for
EV-70 in 11 of the 13 cases, including the 10
culture-confirmed cases.
Conclusions
An outbreak of AHC was first reported from
Ghana in 1969 and was referred to as Apollo
conjunctivitis (6). A new enterovirus (EV-70) was
identified as the etiologic agent of AHC (7);
subsequently it spread to other parts of Africa
and Asia including India.
Figure: Reverse transcriptase-polymerase chain
reaction (RT-PCR) for enteroviral RNA from acute
hemorrhagic conjunctivitis cases. Lane 1: pX174
DNA/Hae III marker; lane 2: negative control; lane 3:
positive control (enteroviral RNA); lanes 4-6: clinical
samples.
For PCR, viral RNA was extracted by the
guanidinium thiocyanate method (2) from 200 µl of
clinical specimen. The RNA pellet was resuspended
in 10 µl of diethyl pyrocarbonate treated water. A
5-µl  volume was used for cDNA synthesis. The
primers used for PCR amplification were selected
from the highly conserved 5' noncoding region of
enterovirus described by Rotbart et al. (3) and, using
the same protocol, cDNA for PCR was synthesized by
reverse transcription. Briefly, cDNA (10µ Cl) was
amplified in a PCR mix volume of 50 µl, containing
100 ng of each primer, 250 µl of each dNTP, 1.5 mM
MgCl2, 2.5 units Taq polymerase, and 5 µl of 10X PCR
buffer. The tubes were subjected to 30 cycles at 94°C
for 1 minute, 58°C for 1 minute, and 72°C for 2
minutes, respectively, followed by a final extension
for 7 minutes at 72°C. A 154-bp sized band of the PCR-
amplified product was visualized under UV
illumination on a 2% agarose gel after ethidium
bromide staining.269 Vol. 5, No. 2, MarchApril 1999 Emerging Infectious Diseases
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The first serologic evidence of EV-70
infection in India came from Bombay (western
India) in 1971-72 (4), and the first isolation was
reported from a single case during a small
epidemic in southern India in 1975 (8). During
an epidemic in north India in 1981 (also during
the rainy season), two isolates of EV-70
prototype (Kono)like strain were reported from
Delhi (5), and antigen-positive cases were found
by immunofluorescence in the city of Chandigarh
(9). The last reported outbreak of EV-70 from this
region (July to September 1986) was also
confirmed only by demonstration of antigen in
cell scrapings by immunofluorescence (10). AHC
due to EV-70 appears to have reemerged in north
India after nearly a decade. During the
intervening period, a coxsackievirus A24 variant
was circulating as a cause of AHC in this region
of India (11). However, a prime-type EV-70
isolate was obtained from a case-patient during
an outbreak in Pune,  western India, nearly
1,200 km from Delhi, in 1991 (12).
In this outbreak of AHC, we achieved an
unusually high isolation rate of EV-70 (10 of 13
cases) by using a modification of centrifugation-
enhanced culture. The results of neutralization
tests indicate that the strains circulating in this
part of India continue to resemble the prototype
strain (also reported during the 1981 epidemic).
PCR was useful because of its rapidity and help
in narrowing the search for an etiologic agent to
enteroviruses. With the availability of PCR
based on EV-70 specific primers (13), this highly
sensitive centrifugation-enhanced technique is
likely to be used increasingly in the future.
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